Exogenous Melatonin in Intensive Care Unit Chronodisruption
NCT03708341
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
98
Enrollment
OTHER
Sponsor class
Conditions
Sleep Deprivation
Intensive Care Psychosis
Interventions
DRUG:
Melatonin 5 mg
DRUG:
Placebo Oral Tablet
Sponsor
Saint-Joseph University